Bayzed Health Group Inc (HKG:2609)
5.00
-0.10 (-1.96%)
Jun 5, 2026, 4:09 PM HKT
Bayzed Health Group Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -12.96 | -13.46 | -26.39 | -58.02 | -46.09 |
Depreciation & Amortization | 87.74 | 85.04 | 84.69 | 73.4 | 49.57 |
Other Amortization | 3.18 | 2.36 | 1.58 | 1.14 | 0.76 |
Loss (Gain) From Sale of Assets | 0.01 | -0 | 0.18 | 0.04 | -0.33 |
Stock-Based Compensation | - | - | - | 0.18 | - |
Provision & Write-off of Bad Debts | 0.48 | 0.65 | 0.27 | 2.06 | 0.46 |
Other Operating Activities | 25.25 | 21.15 | 28.82 | 8.21 | 1.2 |
Change in Accounts Receivable | 17.98 | -86.42 | -26.27 | -33.08 | -29.39 |
Change in Inventory | 2.89 | -3.1 | -3.76 | -7.34 | -13.19 |
Change in Accounts Payable | 123.12 | 232.53 | 67.14 | 46.34 | 70.82 |
Change in Unearned Revenue | -18.17 | -44.84 | -7.8 | 69.33 | 8.86 |
Change in Other Net Operating Assets | -7.17 | -25.37 | 9.91 | 12.13 | -36.26 |
Operating Cash Flow | 222.34 | 168.54 | 128.37 | 114.4 | 6.42 |
Operating Cash Flow Growth | 31.92% | 31.29% | 12.22% | 1683.24% | - |
Capital Expenditures | -33.44 | -43.87 | -45.37 | -29.44 | -49.06 |
Cash Acquisitions | - | - | - | -149.36 | -23.8 |
Sale (Purchase) of Intangibles | -4.47 | -2.58 | -8.44 | -6.91 | -4.92 |
Other Investing Activities | -128.83 | 98.62 | -4.8 | -22.97 | -78.67 |
Investing Cash Flow | -166.74 | 52.17 | -58.61 | -208.68 | -156.45 |
Short-Term Debt Issued | 0.09 | - | - | 6.63 | - |
Long-Term Debt Issued | 265.66 | 206.81 | 243.59 | 184.9 | 70.6 |
Total Debt Issued | 265.74 | 206.81 | 243.59 | 191.53 | 70.6 |
Short-Term Debt Repaid | - | -1.5 | -46.51 | -70.55 | -15.54 |
Long-Term Debt Repaid | -453.63 | -369.85 | -237.93 | -91.65 | -174.37 |
Total Debt Repaid | -453.63 | -371.35 | -284.44 | -162.21 | -189.91 |
Net Debt Issued (Repaid) | -187.89 | -164.54 | -40.85 | 29.32 | -119.31 |
Issuance of Common Stock | 513.13 | 3.6 | 130.87 | 71.11 | 395.12 |
Other Financing Activities | -57.51 | -7.52 | -42.99 | -47.01 | -45.45 |
Financing Cash Flow | 267.74 | -168.46 | 47.04 | 53.43 | 230.36 |
Foreign Exchange Rate Adjustments | -1.61 | - | - | - | - |
Net Cash Flow | 321.73 | 52.25 | 116.8 | -40.86 | 80.32 |
Free Cash Flow | 188.9 | 124.67 | 83 | 84.96 | -42.65 |
Free Cash Flow Growth | 51.53% | 50.20% | -2.30% | - | - |
Free Cash Flow Margin | 16.87% | 10.49% | 7.74% | 10.59% | -9.24% |
Free Cash Flow Per Share | 0.15 | 0.10 | 0.07 | - | - |
Cash Interest Paid | 21.53 | 21.5 | 26.66 | 23.62 | 20.95 |
Cash Income Tax Paid | 18.58 | 27.3 | 20 | 8.98 | 8.55 |
Levered Free Cash Flow | -151.86 | 89.76 | 9.34 | 134.19 | - |
Unlevered Free Cash Flow | -138.41 | 103.19 | 26 | 148.95 | - |
Change in Working Capital | 118.65 | 72.8 | 39.22 | 87.37 | 0.85 |